JPMorgan Chase & Co’s Achilles Therapeutics plc American Depositary Shares ACHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-137
| Closed | -$156 | – | 6658 |
|
|
2024
Q4 | $156 | Hold |
137
| – | – | ﹤0.01% | 5894 |
|
|
2024
Q3 | $140 | Hold |
137
| – | – | ﹤0.01% | 5882 |
|
|
2024
Q2 | $112 | Hold |
137
| – | – | ﹤0.01% | 5844 |
|
|
2024
Q1 | $171 | Sell |
137
-852
| -86% | -$1.06K | ﹤0.01% | 5811 |
|
|
2023
Q4 | $879 | Hold |
989
| – | – | ﹤0.01% | 5814 |
|
|
2023
Q3 | $900 | Hold |
989
| – | – | ﹤0.01% | 5702 |
|
|
2023
Q2 | $935 | Hold |
989
| – | – | ﹤0.01% | 5557 |
|
|
2023
Q1 | $1K | Hold |
989
| – | – | ﹤0.01% | 5695 |
|
|
2022
Q4 | $1K | Sell |
989
-1,388
| -58% | -$1.4K | ﹤0.01% | 5501 |
|
|
2022
Q3 | $5K | Buy |
2,377
+815
| +52% | +$1.71K | ﹤0.01% | 5200 |
|
|
2022
Q2 | $4K | Sell |
1,562
-3,043
| -66% | -$7.79K | ﹤0.01% | 5353 |
|
|
2022
Q1 | $14K | Buy |
4,605
+1,168
| +34% | +$3.55K | ﹤0.01% | 5333 |
|
|
2021
Q4 | $17K | Buy |
+3,437
| New | +$17K | ﹤0.01% | 5363 |
|
|
2021
Q3 | – | Sell |
-49,405
| Closed | -$484K | – | 5803 |
|
|
2021
Q2 | $484K | Sell |
49,405
-576,345
| -92% | -$5.65M | ﹤0.01% | 4017 |
|
|
2021
Q1 | $10.4M | Buy |
+625,750
| New | +$10.4M | ﹤0.01% | 2100 |
|